We are live on ! Find out more
ICPT

Intercept Pharmaceuticals, Inc.
ICPT

Delisted

ICPT was delisted on the 7th of November, 2023.

Back to rankings

57 hedge funds and large institutions have $399M invested in Intercept Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+57
Holders Change %
–
% of All Funds
1.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
57
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$96.4M +$73.5M +2,150,634 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$89.7M +$68.3M +1,999,469 New
VAM
3
Visium Asset Management
New York
$34.4M +$26.2M +766,859 New
BBA
4
Baker Bros. Advisors
New York
$20.8M +$15.8M +462,847 New
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$19.7M +$15M +438,434 New
Capital World Investors
6
Capital World Investors
California
$17.9M +$13.7M +400,000 New
PC
7
PointState Capital
New York
$14.8M +$11.3M +330,000 New
AllianceBernstein
8
AllianceBernstein
Tennessee
$14.4M +$11M +321,239 New
PC
9
Polar Capital
United Kingdom
$13.8M +$10.5M +307,070 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$8.29M +$6.32M +184,866 New
BFA
11
BlackRock Fund Advisors
California
$7.03M +$5.35M +156,684 New
Millennium Management
12
Millennium Management
New York
$6.82M +$5.2M +152,094 New
Lord, Abbett & Co
13
Lord, Abbett & Co
New Jersey
$6.81M +$5.19M +151,913 New
SCA
14
SAC Capital Advisors
Connecticut
$5.61M +$4.27M +125,000 New
JP Morgan Chase
15
JP Morgan Chase
New York
$4.76M +$3.63M +106,209 New
Federated Hermes
16
Federated Hermes
Pennsylvania
$4.48M +$3.42M +100,000 New
Wellington Management Group
17
Wellington Management Group
Massachusetts
$3.63M +$2.77M +81,000 New
Northern Trust
18
Northern Trust
Illinois
$3.38M +$2.57M +75,353 New
BIT
19
BlackRock Institutional Trust
California
$3.16M +$2.4M +70,379 New
State Street
20
State Street
Massachusetts
$2.74M +$2.09M +61,106 New
HCMT
21
Highland Capital Management (Texas)
Texas
$2.25M +$1.72M +50,300 New
EA
22
Emerald Advisers
Pennsylvania
$2.21M +$1.68M +49,175 New
WMSA
23
Weiss Multi-Strategy Advisers
New York
$1.79M +$1.37M +40,000 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$1.32M +$1M +29,357 New
TCIM
25
TIAA CREF Investment Management
New York
$1.12M +$857K +25,071 New
1
2 3

ICPT Hedge Fund Activity: Q2 2013 in Review

57 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q2 2013, worth a combined $399M.

Buyers outnumbered sellers: 57 funds opened new ICPT positions and 0 closed out — a net gain of 57 holders — while 0 added to existing stakes and 0 trimmed.

  • 57 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $399M of Intercept Pharmaceuticals, Inc. stock for Q2 2013.
  • 57 funds opened new Intercept Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +57 holders.

Based on aggregated 13F filings for Q2 2013.